Close menu
Linkedin
img-fluid

Gilles Bos

Chairman of the Board

As an entrepreneur and engineer, I have over 30 years of experience in corporate management and technology development in the MedTech field.

A common thread guides my career choices; combining innovation and strategy in order to match product benefits with the market’s requirements. With this purpose in mind, in 2003, bolstered by years of experience in health care, I created a start-up company in collaboration with my partners, known as Anteis.

By awarding my contribution to the industry in 2008 in the "HIGH-TECH AND BIOTECH" CATEGORY, the experts of the Swiss Economic Forum honored the exceptional services of Anteis in the following fields: innovation, creativity, quality of services, job creation, technological advantage, research & development, and more.

Within 10 years, through focus on developing, manufacturing and marketing injectable Hyaluronic Acid, Anteis became known as a global leader in this particular field. Anteis was acquired by Merz Pharma in 2013.

Since 2013, I have focused on the financing and development of SMEs in various sectors through our global platform, now known as Medaesthetis. I recognize in Medaesthetis a real capacity to propose new technologies in the field of aesthetic treatment. Contributing to the projects on a daily basis, I bring my vision and expertise helping the teams to give their best for the satisfaction of our partners and clients.

Contact

Gilles Bos

Chairman of the Board

As an entrepreneur and engineer, I have over 30 years of experience in corporate management and technology development in the MedTech field.

A common thread guides my career choices; combining innovation and strategy in order to match product benefits with the market’s requirements. With this purpose in mind, in 2003, bolstered by years of experience in health care, I created a start-up company in collaboration with my partners, known as Anteis.

By awarding my contribution to the industry in 2008 in the "HIGH-TECH AND BIOTECH" CATEGORY, the experts of the Swiss Economic Forum honored the exceptional services of Anteis in the following fields: innovation, creativity, quality of services, job creation, technological advantage, research & development, and more.

Within 10 years, through focus on developing, manufacturing and marketing injectable Hyaluronic Acid, Anteis became known as a global leader in this particular field. Anteis was acquired by Merz Pharma in 2013.

Since 2013, I have focused on the financing and development of SMEs in various sectors through our global platform, now known as Medaesthetis. I recognize in Medaesthetis a real capacity to propose new technologies in the field of aesthetic treatment. Contributing to the projects on a daily basis, I bring my vision and expertise helping the teams to give their best for the satisfaction of our partners and clients.

Contact

img-fluid

Meet the rest of the team